Human amniotic membrane transplantation in the treatment of corneal surface diseases;Mise au point sur la membrane amniotique humaine dans la prise en charge des pathologies de la surface oculaire

Journal Francais d'Ophtalmologie

Volumn 24, Issue 5, 2001, Pages 546-556

  Ellies, P ^a   Anderson, D ^b   Dighiero, P ^b   Legeais, J M ^b   Renard, G ^c   Tseng, S S G ^c  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION FLUID; CONJUNCTIVA EPITHELIUM; CORNEA DISEASE; CORNEA EPITHELIUM; HISTOPATHOLOGY; HUMAN; PTERYGIUM; REVIEW; SQUAMOUS CELL METAPLASIA; SURGICAL TECHNIQUE; TISSUE TRANSPLANTATION; TREATMENT INDICATION;

AMNION; CORNEAL DISEASES; HUMANS; METAPLASIA; PERIOPERATIVE CARE; PTERYGIUM; TISSUE PRESERVATION; TREATMENT OUTCOME;

EID: 0034995195     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Important concepts for treating ocular surface and tear disorders
2. Cytologic evidence of corneal diseases with limbal stem cell deficiency
3. Human corneal and conjunctival epithelia express MUC1 mucin
4. Sialomucin complex at the rat ocular surface: A new model for ocular surface protection
5. Contribution of the epithelium to the stability of the tear film
6. Human corneal and conjunctival epithelia produce a mucin-like glycoprotein for the apical surface
7. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation
8. The catalog of human cytokeratins. Patterns of expression in normal epithelia, tumors and cultured cells
9. The major pathways of keratinocyte differentiation as defined by keratin expression, an overview
10. Expression of specific keratin markers by rabbit corneal, conjunctival, and esophageal epithelia during vitamin A deficiency
11. Ocular surface changes in Sjogren's syndrome
12. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes
13. Possible mechanisms for the loss of goblet cells in mucin deficient disorders
14. Keratoprosthesis with biocolonizable microporous fluorocarbon haptic. Preliminary results in a 24 patient study
15. Regulation and clinical implications of corneal epithelial stem cells
16. Concept and application of limbal stem cells
17. Corneal epithelial wound healing in partial limbal deficiency
18. Abnormal corneal epithelial wound healing in partial thickness removal of limbal epithelium
19. Corneal epithelial wound healing in the absence of limbal epithelium
20. Cytologic evidence of corneal diseases with limbal stem cell deficiency
21. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane
22. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency
23. Iatrogenic limbal stem cell deficiency
24. Temporary corneal stem cell dysfunction after radiation therapy
25. Comparison of limbal and conjunctival autograft transplantation for corneal surface reconstruction in rabbits
26. Classification of conjunctival surgeries for corneal disease based on stem cell concept
27. The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system
28. Limbal autograft transplantation for ocular surface disorders
29. Limbal autograft reconstruction after conjunctival squamous cell carcinoma
30. Limbal autograft transplantation, eight consecutive cases
31. Limbal transplantation in the management of chronic contact-lens-associated epitheliopathy
32. Limbal conjunctival autograft in a subacute alkaline corneal burn
33. Limbal transplantation
34. Epithelial transplantation for the management of severe ocular surface disease
35. Limbal autograft transplantations for chronic ocular surface failure
36. Limbal autotransplantation in the acute and chronic phases of severe chemical injuries
37. Limbal allograft transplantation for ocular surface disorders
38. Human allograft limbal transplantation for corneal surface reconstruction
39. Reconstruction of the corneal epithelium by limbal allograft transplantation for severe ocular surface disorders
40. Combined penetrating keratoplasty and limbal allograft transplantation for severe corneal burns
41. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface
42. The amnion in surgery, past and present
43. Plastic repair of conjunctival defects with fetal membrane
44. Amniotic membrane grafts in caustic burns of the eye
45. Further experience with amniotic membrane grafts in caustic burns of the eye
46. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas
47. Localization of type IV and V collagens in the stroma of human amnion
48. The translaminal fibrils of the human amnion basement membrane
49. Differential intrastromal invasion by normal ocular surface epithelia is mediated by different fibroblasts
50. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokynes stimulation
51. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing
52. Type VI collagen increases cell survival and prevents antibeta 1 integrin-mediated apoptosis
53. The role of the basement membrane in differential expression of keratin proteins in epithelial cells
54. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity
55. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
56. Integrin α6/β4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion
57. Basement membrane and human epidermal differentiation in vitro
58. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
59. Amniotic membrane transplantation for persistent epithelial defects with ulceration
60. Amniotic membrane transplantation for conjunctival surface reconstruction
61. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision
62. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome
63. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers
64. Antibacterial properties of human amniotic membrane
65. Role of growth factors for ocular surface reconstruction after amniotic membrane transplantation
66. Conjunctival epithelial differentiation on amniotic membrane
67. Corneal surface reconstruction by amniotic membrane with cultivated autotogous limbo-corneal epithelium
68. Conjunctival epithelial cell differentiation on amniotic membrane
69. Rate of re-epithelialization following amniotic membrane transplantation
70. Amniotic membrane transplantation for ocular surface reconstruction
71. Suppression of TGF-β1, β2, β3, and TGF-β receptor II expression and myofibroblast differentiation in human corneal and limbal fibroblasts by amniotic membrane matrix
72. Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis
73. Corneal haze is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits
74. Temporary amniotic membrane graft promotes healing and inhibits protease activity in corneal wound induced by alkali burns in rabbits
75. Temperature cooling reduces keratocyte death in excimer laser ablated corneal and skin wounds
76. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns
77. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon
78. Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction
79. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers
80. Amniotic membrane transplantation for symptomatic bullous keratopathy
81. Growth factors modulate clonal growth and differentiation of cultured limbal and corneal epithelium
82. Topical treatment with nerve growth factor for corneal neurotrophic ulcers
83. Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation
84. Allograft conjunctival transplantation for bilateral ocular surface disorders
85. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction
86. Use of DNA polymorphisms and the polymerase chain reaction to examine the survival of a human limbal stem cell allograft
87. The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas